Göran Wessman, chairman

Mr. Wessman currently serves as CEO and President of Vita Nova ventures (publ.) the owner company of Vicore Pharma.  Mr. Wessman has long experience of medical companies in management positions and as an entrepreneur in successful ventures in the medical field. 

Anders Sjögren. B.Sc.

Mr. Sjögren currently serves as CFO in Vita Nova Ventures. He has long experience in finance and administration with both established companies and start-ups. Mr. Sjögren has also extensive experience from capital raising activities in the venture capital area.

Björn Dahlöf, M.D., Ph.D.

Dr. Dahlöf is an internist and a specialist in the cardiovascular area. He has successfully designed and initiated several  large clinical trials in phase III and phase IV stages in the cardiovascular area, e.g. the “ASCOT” trial and the “LIFE” trial and most recently the Japanese JIKEI Heart study all published in The Lancet  and with scientific outcomes which have had a profound effect on clinical guidelines. Dr. Dahlöf consequently brings both pre-clinical and clinical expertise to Vicore  Pharma together with an important network of academic collaboration and important high level pharma industry contacts. He has had an interest in the importance of the AT₂receptor since more than 10 years.